Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a312103f-73c1-4a6a-9acd-53daa4b2664a&Preview=1 Date 11/3/2008 Company Name Napera Networks Management, Inc. Mailing Address 7683 SE 27th St Mercer Island, WA 98040 Company Description Napera provides network solutions that enable small and medium enterprises to build safe, secure and healthy networks. Napera solutions leverage Microsoft’s Network Access Protection (NAP) architecture to defend against unauthorized access … Continue reading “Napera Networks Management, Inc. Lands $6,000,000 Series A Financing”
Palo Alto Networks Garners $10,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=77af46cb-afa8-4411-aa3a-40c5b51c0576&Preview=1 Date 11/3/2008 Company Name Palo Alto Networks Mailing Address 232 East Java Drive Sunnyvale, CA 94089-1318 Company Description Palo Alto Networks enables visibility into—and policy-based control over—applications running on enterprise networks. Website http://www.paloaltonetworks.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Undisclosed Proceeds Purposes This new capital will ensure sufficient … Continue reading “Palo Alto Networks Garners $10,000,000 New Funding Round”
Tesla Motors Secures $40,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d3a6b81d-0e6a-4a38-be30-5b0ed0a008cf&Preview=1 Date 11/3/2008 Company Name Tesla Motors Mailing Address 1050 Bing Street San Carlos, CA 94070 Company Description Tesla Motors was founded in June 2003 by Martin Eberhard and Marc Tarpenning to create efficient electric cars for people who love to drive. The company currently employs 70 people, including teams in California, … Continue reading “Tesla Motors Secures $40,000,000 New Financing Round”
RockYou! Receives $17,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bccc5130-6cb7-4354-af11-7179021ee6b1&Preview=1 Date 11/3/2008 Company Name RockYou! Mailing Address 585 Broadway Street Redwood City, CA 94063 Company Description RockYou! creates and distributes the most popular self-expression widgets on the web. RockYou!’s viral accessories can be used to enhance the look and feel of any blog, personal website, and are used on social networks … Continue reading “RockYou! Receives $17,000,000 New Funding”
Impeva Labs Receives $10,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01e1d261-184f-4538-9938-8b4f934729e9&Preview=1 Date 11/3/2008 Company Name Impeva Labs Mailing Address 2570 West El Camino Real Mountain View, CA 94040-1309 Company Description Impeva Labs is the leading supplier of global asset management optimization (tracking, monitoring and security) solutions that enable the most efficient transportation of goods by providing a Continuous Chain of Custody (C-3) … Continue reading “Impeva Labs Receives $10,000,000 Series B Financing Round”
Vertex Drug for Hepatitis C Shows Durable Virus-Killing Ability in Tough-to-Treat Patients
More data is rolling in from Vertex Pharmaceuticals on its lead drug for hepatitis C, and it looks like the medicine is continuing to live up to its own high expectations. The Cambridge, MA-based company said today that telaprevir’s effect on killing the virus is remaining durable on follow-up analysis, and the drug appears to … Continue reading “Vertex Drug for Hepatitis C Shows Durable Virus-Killing Ability in Tough-to-Treat Patients”
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds
Anadys Pharmaceuticals may not be first in a new class of emerging drugs for hepatitis C, but it’s aiming to show this weekend it’s a contender. The San Diego-based company is reporting today that its lead drug candidate was found safe at a variety of doses in a clinical trial of 48 healthy volunteers, and … Continue reading “Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds”
MediQuest Fails to Win FDA Approval for Raynaud’s Drug
MediQuest Therapeutics, a Bothell, WA-based developer of a drug for Raynaud’s disease, said the FDA has turned down its application to market the product in the U.S. The FDA said the company’s application to market Vascana, a squeeze-on gel to improve blood circulation in the hands and feet, “could not be approved in its present … Continue reading “MediQuest Fails to Win FDA Approval for Raynaud’s Drug”
Fidelity Biosciences Pumps $65M into EnVivo Pharma
Fidelity Biosciences has invested $65 million in EnVivo Pharmaceuticals, a Watertown, MA-based developer of drugs for Alzheimer’s and schizophrenia, in a Series D venture financing round, according to this report on Fierce Biotech from Dow Jones VentureWire. The Boston-based fund bought out all of the company’s other investors, including BCM Technologies, Cogene Ventures, and NeuroVentures … Continue reading “Fidelity Biosciences Pumps $65M into EnVivo Pharma”
Democratic Party Fundraiser Dies, After Friends and Family Pushed To Get Him Tysabri
Fred Baron, the prominent Democratic Party fundraiser, died Thursday after a high-profile effort to obtain Biogen Idec and Elan’s natalizumab (Tysabri) to save his life from an aggressive cancer, according to this report from the Associated Press. Baron, 61, received help more than two weeks ago from a group of friends including former President Bill … Continue reading “Democratic Party Fundraiser Dies, After Friends and Family Pushed To Get Him Tysabri”
Second Ave Re-ups with Ice Energy
Seattle-based Second Avenue Partners has participated in a $33 million Series B funding for Colorado-based Ice Energy, a cleantech company that helps manage electricity usage for air conditioning. Second Avenue was an original investor in Ice Energy. The latest funding round was led by Energy Capital Partners.
San Diego and von Liebig Center Award First Grants Under New Cleantech Initiative
San Diego has been looking into the expanding pool of renewable “cleantech” technologies and trying to see a reflection of itself. To make that vision a reality, city and economic development officials embarked last year on an initiative intended to promote cleantech in this sun-drenched land. The initiative began with a study that found 148 cleantech companies in the region, the beginnings … Continue reading “San Diego and von Liebig Center Award First Grants Under New Cleantech Initiative”
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker
Don’t be confused by the name of the Novartis Option Fund. The fund’s purpose isn’t to gain options in companies for Swiss drug giant Novartis to later acquire, says Lauren Silverman, the fund’s managing director. And it isn’t a traditional corporate VC firm that operates as an extension of the parent company. Rather, Silverman prefers … Continue reading “Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker”
Supporter of Seattle Startups Raises $800K for “Social Analytics,” Wants To Improve Your Website
One of the most influential people in the Seattle tech-innovation scene doesn’t even live in the area. He’s Neil Patel, and if you’re in the Web analytics or Internet marketing business, you already know who he is. That’s because Patel has done marketing and search engine optimization for everyone from giants like General Motors, AOL, … Continue reading “Supporter of Seattle Startups Raises $800K for “Social Analytics,” Wants To Improve Your Website”
Ceregene Awaits Parkinson’s Trial Results, In a Key Test for Gene Therapy
A critical turning point is coming for Ceregene by the end of the year. The San Diego-based biotech company expects to get results in the next couple months on whether its experimental gene therapy can effectively help treat Parkinson’s disease. I got the overview of what this is all about a few weeks ago during … Continue reading “Ceregene Awaits Parkinson’s Trial Results, In a Key Test for Gene Therapy”
In Google Book Search Settlement, Readers Lose
The biggest development in the digital media world this week, by far, was the settlement of a pair of class-action copyright-infringement lawsuits brought against Google in 2005 by the Authors Guild, the Association of American Publishers, and several publishing houses. The compromise agreement, which was announced October 28 and now awaits approval by the federal … Continue reading “In Google Book Search Settlement, Readers Lose”
EnVivo Pharmaceuticals, Inc. Garners $65,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2a76d669-2356-44a2-8d5e-098484c2bbec&Preview=1 Date 10/31/2008 Company Name EnVivo Pharmaceuticals, Inc. Mailing Address 480 Arsenal Street, Building 1 Watertown, MA 02472 Company Description EnVivo is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders. CNS disorders account for more hospitalizations, long-term care, and chronic suffering than nearly all other … Continue reading “EnVivo Pharmaceuticals, Inc. Garners $65,000,000 New Financing Round”
Xtalic Corporation Lands $10,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=772e6d91-56b4-4b8f-a079-9a724c18398d&Preview=1 Date 10/31/2008 Company Name Xtalic Corporation Mailing Address 260 Cedar Hill Street Marlborough, MA 01752 Company Description Xtalic is focused on providing new nanostructured alloys for use in the hard metal coatings industry. Our new technology allows us to precisely tailor the properties of metallic coatings by controlling their structure at … Continue reading “Xtalic Corporation Lands $10,000,000 Series B Funding”
Nanostim Inc Lands $9,700,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e16b02f-ed15-4550-8b43-95bcc268d062&Preview=1 Date 10/31/2008 Company Name Nanostim Inc Mailing Address 3510 Tres Rios Sa Clemente, CA 92673 Company Description Nanostim Inc is a developer of miniaturized, leadless cardiac pacemakers. Website Undisclosed Transaction Type Venture Equity Transaction Amount $9,700,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Nanostim Inc Lands $9,700,000 Series A Round”
Cebix Inc Secures $2,850,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=49530e11-0f64-4edb-93fb-d3907ab52a29&Preview=1 Date 10/31/2008 Company Name Cebix Inc Mailing Address 120 Prospect Street Ocean Level – 4 La Jolla, CA 92037 Company Description Cebix Inc is a biopharma startup. Website Undisclosed Transaction Type Venture Equity Transaction Amount $2,850,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Cebix Inc Secures $2,850,000 Series A Financing Round”
Permuto Receives $6,030,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=14895dc6-d406-423b-8fbb-5b7d5fea860b&Preview=1 Date 10/31/2008 Company Name Permuto Mailing Address 550 College Ave Palo Alto, CA 94306 Company Description Permuto, Inc. is a newly funded company in stealth mode founded by veterans of Yahoo!, Doubleclick, Rhythm NewMedia, Apple, Oracle, Microsoft, and Excite@Home. Website http://www.permuto.com Transaction Type Venture Equity Transaction Amount $6,030,000 Transaction Round Series … Continue reading “Permuto Receives $6,030,000 Series A Funding Round”
Syncplicity Receives $2,350,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a574ed17-8344-4e9d-a997-928deaddb399&Preview=1 Date 10/31/2008 Company Name Syncplicity Mailing Address 1136 Eddy Street San Francisco, CA 94109 Company Description Syncplicity was founded with a simple vision: Your computer should empower you, not slow you down. Our goal is to create a new way of managing files to liberate people from worrying about how and … Continue reading “Syncplicity Receives $2,350,000 Series A Financing Round”
Novariant Garners $40,000,000 Series D Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=20940633-a5e0-43c1-b245-a26590e02ffc&Preview=1 Date 10/31/2008 Company Name Novariant Mailing Address 45700 Northport Loop East Fremont, CA 94538 Company Description Novariant is the premier industrial solutions provider for precision positioning, intelligent control systems and positioning infrastructures. Website http://www.novariant.com Transaction Type Venture Equity Transaction Amount $40,000,000 Transaction Round Series D Proceeds Purposes Proceeds purposes were not … Continue reading “Novariant Garners $40,000,000 Series D Financing Round”
Calisolar Obtains $51,900,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=89056b52-0e5f-4c69-9fc2-bcd046c2ff28&Preview=1 Date 10/31/2008 Company Name Calisolar Mailing Address 985 Almanor Ave Sunnyvale, CA 94085 Company Description CaliSolar is a photovoltaic (PV) company that designs, patents, manufactures and markets solar cells in high volumes for the largest segments of the PV industry. Website http://www.calisolar.com Transaction Type Venture Equity Transaction Amount $51,900,000 Transaction Round … Continue reading “Calisolar Obtains $51,900,000 Series B Round”
Qualcomm and Amobee Media Systems Develop Mobile Advertising
San Diego-based Qualcomm and Amobee Media Systems of Redwood City CA said today they are working together to offer mobile advertising on Qualcomm’s Plaza solution. Amobee and Qualcomm integrated Amobee’s ad-serving technology with Plaza, Qualcomm’s platform-agnostic service that provides a framework for developing mobile widgets-Web-based applications.
Accumetrics Adds ‘CEO’ to Still’s Title
San Diego’s Accumetrics has named Tim Still, who has been serving as president and chief operating officer since earlier this year, to the additional position of chief executive. Accumetrics provides doctors with an automated device for measuring platelets, enabling them to assess their patients’ response to anti-platelet drugs prescribed to help prevent heart attack, strokes … Continue reading “Accumetrics Adds ‘CEO’ to Still’s Title”
Sonosite Buys Back $60M of Convertible Debt
Sonosite, the Bothell, WA-based maker of portable ultrasound machines, said today has bought back $60.3 million worth of convertible notes it owes to investors. The company (NASDAQ: [[ticker:SONO]]) said it paid about $47.4 million in cash through the transaction, and recorded a pre-tax gain of $11 million. It still has $164.7 million million of these … Continue reading “Sonosite Buys Back $60M of Convertible Debt”
Arena Buys Back $55.8M in Stock
San Diego-based Arena Pharmaceuticals said today it is spending $55.8 million in cash to buy back all of its outstanding convertible stock. The company (NASDAQ: [[ticker:ARNA]]) expects to buy the shares on Nov. 13, it said in a statement. Arena, the developer of lorcaserin for obesity, now expects to finish the year with $115 million … Continue reading “Arena Buys Back $55.8M in Stock”
Kashless No More: Martin Tobias Raises $5M for New Startup
[Updated Oct. 30 with comments from Tobias, who’s surfing in Hawaii (see below)] Although he has been stingy with details about his new startup, Kashless, I figured Seattle entrepreneur Martin Tobias had to have raised some money (he’s been hiring). Yesterday, Dan Primack of PEHub reported that Kashless recently closed a $5 million Series A … Continue reading “Kashless No More: Martin Tobias Raises $5M for New Startup”
NxtGen Emission Nets $15.4M
Burnaby, BC-based NxtGen Emission Controls announced today it has closed a $15.4 million Series B round, led by Denver, CO-based Altira Group. Other investors included Itochu, an undisclosed Japanese auto maker, and return investors Yaletown Venture Partners, GrowthWorks Capital, BC Advantage Funds, and Polygon Financial Investments. NxtGen Emission specializes in “syngas” technology for reducing emissions … Continue reading “NxtGen Emission Nets $15.4M”
Financial Crisis Already Having Moderate Impact on Washington Tech Businesses, Survey Says
Three weeks ago, the Washington Technology Industry Association (WTIA) launched a survey on the effects of the economic downturn on the technology community. The specific goal was to get feedback on how tech businesses are being directly affected by the nation’s financial crisis. Xconomy was the exclusive media partner on the survey; we had early … Continue reading “Financial Crisis Already Having Moderate Impact on Washington Tech Businesses, Survey Says”
Boston-Power Expands Lithium Ion R&D Lab, Sets Eyes on Batteries for Transportation
Boston-Power, which makes advanced lithium-ion battery packs for notebook computers, is planning a ribbon-cutting ceremony today for its newly expanded research and development facilities in Westborough, MA. I caught up with CEO Christina Lampe-Onnerud by phone this morning as she prepared for the event, where a number of local business leaders and state officials plan … Continue reading “Boston-Power Expands Lithium Ion R&D Lab, Sets Eyes on Batteries for Transportation”
Sequenom Licenses IP for Maternal Urine Tests
Sequenom (NASDAQ:[[ticker:SQNM]]), a San Diego-based provider of molecular diagnostics, reports that it has licensed exclusive rights from Monmouth Junction, NJ, diagnostics firm Xenomics (PINK:[[ticker:XNOM]]) to U.S. and European patents that cover the use of fetal DNA fragments found in a mother’s urine for prenatal diagnostics and research. As Luke discusses in this story, Sequenom is … Continue reading “Sequenom Licenses IP for Maternal Urine Tests”
Dyax Lands Deal to Raise $50M
Dyax (NASDAQ:[[ticker:DYAX]]), a Cambridge, MA-based biotech firm, and investment fund Azimuth Opportunity have struck a deal under which Dyax may sell up to $50 million of its common stock to Azimuth over an 18-month period, Dyax reports. Dyax CFO George Migausky stated that the agreement, which does not obligate Dyax to sell any shares to … Continue reading “Dyax Lands Deal to Raise $50M”
Can The Echo Nest Stay Aloft in the Turbulent Music-Recommendation Industry?
As I walked through a windy, chilly Somerville on my way to visit music-discovery startup The Echo Nest yesterday, last weekend’s sudden shutdown at Matchmine weighed on my mind. After all, The Echo Nest is in the same general business as the now-defunct Needham, MA, company: building software that helps digital media companies provide Web … Continue reading “Can The Echo Nest Stay Aloft in the Turbulent Music-Recommendation Industry?”
Grim San Diego Panel Urges Venture Community and Entrepreneurs to Get Realistic
The turnout was heavier than expected as the San Diego Venture Group convened its monthly breakfast meeting yesterday for a program on “Company Financing Alternatives in a Challenging Environment.” Coordinators had arranged tables for 300 in the outdoor pavilion at the Hyatt Regency La Jolla. But interest was so high in the topic that several … Continue reading “Grim San Diego Panel Urges Venture Community and Entrepreneurs to Get Realistic”
Alnara Pharmaceuticals Aims to Make Biotech Drugs You Can Swallow, And That Go Right Where They Belong
Despite all the red ink in investors’ portfolios, there is still venture money out there for big ideas. Boston-based Alnara Pharmaceuticals has snapped up $20 million in a first-round financing to support a novel, untested concept. The company wants to show it can develop biotech drugs that can be given in an oral pill, and … Continue reading “Alnara Pharmaceuticals Aims to Make Biotech Drugs You Can Swallow, And That Go Right Where They Belong”
ZymoGenetics Trial Halted, Amgen’s Big New Drug, Spiration Gets FDA Nod, & More Seattle-Area Life Sciences News
Seattle biotech had its usual highlights and lowlights this week. One local company won its first FDA approval, of a minimally invasive device for lung disease. Another regional bellwether had a clinical trial failure that sent its stock down 29 percent in a day. Lots of politicians were showing up on the innovation scene this … Continue reading “ZymoGenetics Trial Halted, Amgen’s Big New Drug, Spiration Gets FDA Nod, & More Seattle-Area Life Sciences News”
Buy-Side Experts See Major Changes Afoot for Biotech Amid Financial Crisis
Unless there are more than seven figures in your personal net worth or you happen to manage a pension fund or the like, there are few chances to glean information from hedge fund managers and other buy-side experts who play the high-risk game of biotech investing. Yet last week one of those rare opportunities presented … Continue reading “Buy-Side Experts See Major Changes Afoot for Biotech Amid Financial Crisis”
Sourcing the Right Crowd
Commercialization is rarely a solitary pursuit; bringing an idea to the world requires a set of diverse skills and knowledge, a proverbial commercialization village. Or a crowd. Enter the power of crowdsourcing. Crowdsourcing refers to aggregating a large number of people to express their opinions or ideas about specific topics—and the term first appeared in … Continue reading “Sourcing the Right Crowd”
Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f73e5a0f-536f-4a0d-9ef0-9c66d2a3c3c8&Preview=1 Date 10/30/2008 Company Name Alnara Pharmaceuticals Inc Mailing Address 800 Boylston Street Boston, MA 02199 Company Description Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases. Website http://www.alnara.com Transaction Type Venture Equity Transaction Amount $20,000,000 Transaction Round Series A Proceeds … Continue reading “Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round”
P&H Therapeutics Inc Receives $500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=50fccf7b-ce83-46b1-899b-b4f2440d6f5a&Preview=1 Date 10/30/2008 Company Name P&H Therapeutics Inc Mailing Address Undisclosed Providence, RI 02900 Company Description P&H Therapeutics Inc is a company developing next-generation drugs to treat hypertension and dyslipidemia. Website Undisclosed Transaction Type Venture Equity Transaction Amount $500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture … Continue reading “P&H Therapeutics Inc Receives $500,000 New Funding”
Solar City Lands $30,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc597603-da18-4035-af9c-0808977b9f28&Preview=1 Date 10/30/2008 Company Name Solar City Mailing Address 393 Vintage Park Drive Foster City, CA 94404 Company Description SolarCity matches advanced solar power technology with a suite of installation services. The company’s comprehensive offering removes the technical, regulatory, and financing barriers to solar power, helping customers make smart renewable energy choices … Continue reading “Solar City Lands $30,000,000 New Financing”
Allopartis Technologies Lands New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e2a5723-161c-430c-915c-1171673bad61&Preview=1 Date 10/30/2008 Company Name Allopartis Technologies Mailing Address Undisclosed San Francisco, CA 94000 Company Description Allopartis Biotechnologies is a company in the biofuel industry. Website http://www.allopartis.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor X/Seed Capital
HID Laboratories Garners New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b93e584f-6922-47e8-a81f-aceb1494793f&Preview=1 Date 10/30/2008 Company Name HID Laboratories Mailing Address 200 Middlefield Road Menlo Park, CA 94025 Company Description HID Laboratories develops intelligent, commercial-grade, high intensity lighting solutions that provide a smart platform to dynamically manage lighting demand, and dramatically reduce energy use. Our unique and environmentally sustainable technology, along with our commitment … Continue reading “HID Laboratories Garners New Financing”
IT and the Future of Clinical Trials
The Washington Biotechnology & Biomedical Association is hosting an event at the Microsoft campus on Wednesday, November 12th, to learn more about Microsoft’s vision for life sciences, and its potential implications for the clinical trial process of the future. Attendees of “Information Technology and the Future of Clinical Trials” will also hear from Bob Webber, … Continue reading “IT and the Future of Clinical Trials”
Startups Aren’t Dead, Says ClayValet Founder in Wake of Shutdown
You usually only hear about startups when they’re successful, but Seattle-based ClayValet is an exception. Two weeks ago, founder Mikhail Seregine announced that he was shutting down his four-person company, an online shopping service that allowed customers to ask questions about products and get personal recommendations. He followed up this week with a really informative … Continue reading “Startups Aren’t Dead, Says ClayValet Founder in Wake of Shutdown”
Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection
Tysabri has been linked to its first U.S. case of an often-deadly brain infection since it was re-introduced to the domestic market two years ago. Cambridge, MA-based Biogen Idec (NASDAQ: [[ticker:BIIB]]) and its partner Elan said today they have notified regulators that a rare brain infection called PML has been diagnosed in a patient with … Continue reading “Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection”
Vlingo Upgrades Blackberry App
Cambridge, MA, startup Vlingo today launched a drastically improved version of its voice command and speech-to-text interface for RIM Blackberry smartphones, first released in June. The free vlingo 2.0 software, which works on Blackberry Pearl, Curve, and 8800 series phones, not only allows users to compose text messages and e-mails by speaking into their phones, … Continue reading “Vlingo Upgrades Blackberry App”
Italy-US Bio Nano Business Forum 2008
The Italian Trade Commission is sponsoring this full-day forum to promote partnership and to foster relationships between the Italian and U.S. biotech and nanotech communities. Topics include biosafety bssues in a globalized world, jumpstarting biotechnology/nanotechnology development, and emerging approaches to cancer detection, development, and therapy. Check out the complete agenda at forum registration web site.